Genetic networks governing heart development

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 11, 2014, Pages

  Waardenberg, Ashley J ^a   Ramialison, Mirana ^a,b,d,e   Bouvere, Romaric ^a,b   Harvey, Richard P ^a,b,c,d  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Training Program NSW   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Monash University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; MESSENGER RNA; MICRORNA; NUCLEAR RNA; RNA POLYMERASE II; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; UNTRANSLATED RNA;

ARTICLE; CELL FATE; ENHANCER REGION; EPIGENETICS; FRUIT FLY MODEL; GENE REGULATORY NETWORK; HEART; HEART DEVELOPMENT; HUMAN; MACHINE LEARNING; NONHUMAN; PLURIPOTENT STEM CELL; SYSTEMS BIOLOGY; TRANSCRIPTION REGULATION; ANIMAL; DROSOPHILA; EMBRYOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GENOME; GROWTH, DEVELOPMENT AND AGING; MOUSE; MUSCULOSKELETAL DEVELOPMENT; PHYSIOLOGY;

ANIMALIA;

ANIMALS; DROSOPHILA; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; GENOME; HEART; HUMANS; MICE; MUSCULOSKELETAL DEVELOPMENT; RNA, UNTRANSLATED;

EID: 84923931488     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a013839     Document Type: Article

References (131)

1. Ahmad SM, Busser BW, Huang D, Cozart EJ, Michaud S, Zhu X, Jeffries N, Aboukhalil A, Bulyk ML, Ovcharenko I, et al. 2014. Machine learning classification of cell-specific cardiac enhancers uncovers developmental subnetworks regulating progenitor cell division and cell fate specification. Development 141: 878–888.
2. Alon U. 2007. Network motifs: Theory and experimental approaches. Nat Rev Genet 8: 450–461.
3. Anderson RH, Spicer DE, Brown NA, Mohun TJ. 2014. The development of septation in the four-chambered heart. Anat Rec (Hoboken) doi: 10.1002/ar.22949.
4. Barabasi AL, Albert R. 1999. Emergence of scaling in random networks. Science 286: 509–512.
5. Barabasi AL, Bonabeau E. 2003. Scale-free networks. Sci Am 288: 60–69.
6. Barolo S, Posakony JW. 2002. Three habits of highly effective signaling pathways: Principles of transcriptional control by developmental cell signaling. Genes Dev 16: 1167–1181.
7. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV, Hannon GJ. 2003. Dicer is essential for mouse development. Nat Genet 35: 215–217.
8. Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rucker-Martin C, Barbry P, Bel A, et al. 2010. Apurified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells en engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120: 1125–1139.
9. Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F, et al. 2010. ChIP-Seq identification of weakly conserved heart enhancers. Nat Genet 42: 806–810.
10. Bollini S, Vieira JM, Howard S, Dube KN, Balmer GM, Smart N, Riley PR. 2014. Re-activated adult epicardial progenitor cells are a heterogeneous population molecularly distinct from their embryonic counterparts. Stem Cells Dev doi: 10.1089/scd.2014.0019.
11. Bolouri H, Davidson EH. 2003. Transcriptional regulatory cascades in development: Initial rates, not steady state, determine network kinetics. Proc Natl Acad Sci 100: 9371–9376.
12. Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, Kyba M, Blanpain C. 2008. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 3: 69–84.
13. Bondue A, Tannler S, Chiapparo G, Chabab S, Ramialison M, Paulissen C, Beck B, Harvey R, Blanpain C. 2011. Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiation. J Cell Biol 192: 751–765.
14. Bonn S, Zinzen RP, Girardot C, Gustafson EH, Perez-Gonzalez A, Delhomme N, Ghavi-Helm Y, Wilczynski B, Riddell A, Furlong EE. 2012. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat Genet 44: 148–156.
15. Britten RJ, Davidson EH. 1969. Gene regulation for higher cells: A theory. Science 165: 349–357.
16. Brown CO 3rd, Chi X, Garcia-Gras E, Shirai M, Feng XH, Schwartz RJ. 2004. The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer. J Biol Chem 279: 10659–10669.
17. Busser BW, Bulyk ML, Michelson AM. 2008. Toward a systemslevel understanding of developmental regulatory networks. Curr Opin Genet Dev 18: 521–529.
18. Carmena A, Buff E, Halfon MS, Gisselbrecht S, Jimenez F, Baylies MK, Michelson AM. 2002. Reciprocal regulatory interactions between the Notch and Ras signaling pathways in the Drosophila embryonic mesoderm. Dev Biol 244: 226–242.
19. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al. 2005. The transcriptional landscape of the mammalian genome. Science 309: 1559–1563.
20. Chan SS, Kyba M. 2013. What is a master regulator? J Stem Cell Res Ther 3: 114.
21. Chen JX, Plonowska K, Wu SM. 2014. Somatic cell reprogramming into cardiovascular lineages. J Cardiovasc Pharmacol doi: 10.1177/1074248414527641.
22. Cheutin T, Cavalli G. 2014. Polycomb silencing: From linear chromatin domains to 3D chromosome folding. Curr Opin Genet Dev 25C: 30–37.
23. Chowdhury S, Erickson SW, MacLeod SL, Cleves MA, Hu P, Karim MA, Hobbs CA. 2011. Maternal genome-wide DNA methylation patterns and congenital heart defects. PLoS ONE 6: 16506.
24. Christiaen L, Stolfi A, Davidson B, Levine M. 2009. Spatiotemporal intersection of Lhx3 and Tbx6 defines the cardiac field through synergistic activation ofMesp. Dev Biol 328: 552–560.
25. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. 2011. Genomic maps of long noncodingRNAoccupancy reveal principles of RNA-chromatin interactions. Mol Cell 44: 667–678.
26. Cohen ED, Tian Y, Morrisey EE. 2008. Wnt signaling: An essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 135: 789–798.
27. Cortes C, Vapnik V. 1995. Support-vector networks. In Machine learning, pp. 273–297. Kluwer Academic, Hingham, MA.
28. Costello I, Pimeisl IM, Drager S, Bikoff EK, Robertson EJ, Arnold SJ. 2011. The T-box transcription factor Eomesodermin acts upstream of Mesp1 to specify cardiac mesoderm during mouse gastrulation. Nat Cell Biol 13: 1084–1091.
29. David R, Jarsch VB, Schwarz F, Nathan P, Gegg M, Lickert H, Franz WM. 2011. Induction of MesP1 by Brachyury(T) generates the common multipotent cardiovascular stem cell. Cardiovasc Res 92: 115–122.
30. Davidson EH, Erwin DH. 2006. Gene regulatory networks and the evolution of animal body plans. Science 311: 796–800.
31. Davidson EH, Rast JP, Oliveri P, Ransick A, Calestani C, Yuh CH, Minokawa T, Amore G, Hinman V, Arenas-Mena C, et al. 2002. A genomic regulatory network for development. Science 295: 1669–1678.
32. Delgado-Olguin P, Huang Y, Li X, Christodoulou D, Seidman CE, Seidman JG, Tarakhovsky A, Bruneau BG. 2012. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat Genet 44: 343–347.
33. Dodou E, Verzi MP, Anderson JP, Xu SM, Black BL. 2004. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mou e embryonic development. Development 131: 3931–3942.
34. Elliott DA, Kirk EP, Schaft D, Harvey RP. 2010. NK-2 class homeodomain proteins: Conserved regulator of cardiogenesis. In Heart development and regeneration (ed. Rosenthal N, Harvey RP), pp. 569–597. Elsevier, New York.
35. Ellison GM, Vicinanza C, Smith AJ, Aquila I, Leone A, Waring CD, Henning BJ, Stirparo GG, Papait R, Scarfo M, et al. 2013. Adult c-kitpos cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154: 827–842.
36. Enver T, Pera M, Peterson C, Andrews PW. 2009. Stem cell states, fates, and the rules of attraction. Cell Stem Cell 4: 387–397.
37. Erceg J, Saunders TE, Girardot C, Devos DP, Hufnagel L, Furlong EE. 2014. Subtle changes in motif positioning cause tissue-specific effects on robustness of an enhancer’s activity. PLoS Genet 10: e1004060.
38. Ernst J, Kellis M. 2010. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 28: 817–825.
39. Fantom Consortium. 2014. A promoter-level mammalian expression atlas. Nature 507: 462–470.
40. Friedman N. 2004. Inferring cellular networks using probabilistic graphical models. Science 303: 799–805.
41. Garcia-Bellido A. 1975. Genetic control of wing disc development in Drosophila. In Ciba Foundation Symposium 29—Cell patterning (ed. Porter R, Rivers J),Wiley, Chichester,UK.
42. Grego-Bessa J, Luna-Zurita L, delMonte G, Bolos V, Melgar P, Arandilla A, Garratt AN, Zang H, Mukouyama YS, Chen H, et al. 2007. Notch signaling is essential for ventricular chamber development. Dev Cell 12: 415–429.
43. Grote P, Wittler L, Hendrix D, Koch F, Wahrisch S, Beisaw A, Macura K, Blass G, Kellis M, Werber M, et al. 2013. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell 24: 206–214.
44. Gurdon JB. 1988. A community effect in animal development. Nature 336: 772–774.
45. Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al. 2011. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477: 295–300.
46. Han P, Hang CT, Yang J, Chang CP. 2011. Chromatin remodeling in cardiovascular development and physiology. Circ Res 108: 378–396.
47. Harrison NJ, Baker D, Andrews PW. 2007. Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int J Androl 30: 275–281; discussion 281.
48. He A, Kong SW, Ma Q, Pu WT. 2011. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci 108: 5632–5637.
49. Herrmann F, Gross A, Zhou D, Kestler HA, Kuhl M. 2012. A boolean model of the cardiac gene regulatory network determining first and second heart field identity. PLoS ONE 7: 46798.
50. Holler KL, Hendershot TJ, Troy SE, Vincentz JW, Firulli AB, Howard MJ. 2010. Targeted deletion of Hand2 in cardiac neural crest-derived cells influences cardiac gene expression and outflow tract development. Dev Biol 341: 291-304.
51. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. 2010. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142: 375–386.
52. Jaitin DA, Kenigsberg E, Keren-Shaul H, Elefant N, Paul F, Zaretsky I, Mildner A, Cohen N, Jung S, Tanay A, et al. 2014. Massively parallel single-cell RNA-seq for markerfree decomposition of tissues into cell types. Science 343: 776–779.
53. Jakobsen JS, Braun M, Astorga J, Gustafson EH, Sandmann T, Karzynski M, Carlsson P, Furlong EE. 2007. Temporal ChIP-on-chip reveals Biniou as a universal regulator of the visceral muscle transcriptional network. Genes Dev 21: 2448–2460.
54. Jeong H, Mason SP, Barabasi AL, Oltvai ZN. 2001. Lethality and centrality in protein networks. Nature 411: 41–42.
55. Jin H, Stojnic R, Adryan B, Ozdemir A, Stathopoulos A, Frasch M. 2013. Genome-wide screens for in vivo Tin-man binding sites identify cardiac enhancers with diverse functional architectures. PLoS Genet 9: e1003195.
56. Junion G, Bataille L, Jagla T, Da Ponte JP, Tapin R, Jagla K. 2007. Genome-wide view of cell fate specification: Ladybird acts at multiple levels during diversification of muscle and heart precursors. Genes Dev 21: 3163–3180.
57. Junion G, Spivakov M, Girardot C, Braun M, Gustafson EH, Birney E, Furlong EEM. 2012. A transcription factor collective defines cardiac cell fate and reflects lineage history. Cell 148: 473–486.
58. Kauffman SA. 1969. Metabolic stability and epigenesis in randomly constructed genetic nets. J Theor Biol 22: 437–467.
59. Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, Ding H, Butty VL, Torrey L, Haas S, et al. 2013. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell 152: 570–583.
60. Kulkarni MM, Arnosti DN. 2003. Information display by transcriptional enhancers. Development 130: 6569–6575.
61. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860–921.
62. Lara-Pezzi E, Dopazo A, Manzanares M. 2012. Understanding cardiovascular disease: A journey through the genome (and what we found there). Dis Model Mech 5: 434–443.
63. Lavine KJ, Yu K, White AC, Zhang X, Smith C, Partanen J, Ornitz DM. 2005. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell 8: 85–95.
64. Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, Molkentin JD. 2001. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 21: 7460–7469.
65. Liu Y, Kaneda R, Leja TW, Subkhankulova T, Tolmachov O, Minchiotti G, Schwartz RJ, Barahona M, Schneider MD. 2014. Hhex and cer1 mediate the sox17 pathway for cardiac mesoderm formation in embryonic stem cells. Stem Cells 32: 1515–1526.
66. Mann RS, Carroll SB. 2002. Molecular mechanisms of selector gene function and evolution. Curr Opin Genet Dev 2: 592–600.
67. Martin DI, Cropley JE, Suter CM. 2011. Epigenetics in disease: Leader or follower? Epigenetics 6: 843–848.
68. May D, Blow MJ, Kaplan T, McCulley DJ, Jensen BC, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, et al. 2012. Large-scale discovery of enhancers from human heart tissue. Nat Genet 44: 89–93.
69. Mbodj A, Junion G, Brun C, Furlong EE, Thieffry D. 2013. Logical modelling of Drosophila signalling pathways. Mol Biosyst 9: 2248–2258.
70. Mitchell KJ. 2007. The genetics of brain wiring: From molecule to mind. PLoS Biol 5: e113.
71. Morris KV, Mattick JS. 2014. The rise of regulatory RNA. Nat Rev Genet 15: 423–437.
72. Naqvi N, Li M, Calvert JW, Tejada T, Lambert JP, Wu J, Kesteven SH, Holman SR, Matsuda T, Lovelock JD, et al. 2014. A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell 157: 795–807.
73. Narlikar L, Sakabe NJ, Blanski AA, Arimura FE, Westlund JM, Nobrega MA, Ovcharenko I. 2010. Genome-wide discovery of human heart enhancers. Genome Res 20: 381–392.
74. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, Beck AE, Tabor HK, Cooper GM, Mefford HC, et al. 2010. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 42: 790–793.
75. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ, Kaneda Y. 2009. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 toWolf–Hirschhorn syndrome. Nature 460: 287–291.
76. Noseda M, Peterkin T, Simoes FC, Patient R, SchneiderMD. 2011. Cardiopoietic factors: Extracellular signals for cardiac lineage commitment. Circ Res 108: 129–152.
77. Oliveri P, Tu Q, Davidson EH. 2008. Global regulatory logic for specification of an embryonic cell lineage. Proc Natl Acad Sci 105: 5955–5962.
78. Olson EN. 2006. Gene regulatory networks in the evolution and development of the heart. Science 313: 1922–1927.
79. Orkin SH, Hochedlinger K. 2011. Chromatin connections to pluripotency and cellular reprogramming. Cell 145: 835–850.
80. Paige SL, Thomas S, Stoick-Cooper CL, Wang H, Maves L, Sandstrom R, Pabon L, Reinecke H, Pratt G, Keller G, et al. 2012. A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell 151: 221–232.
81. Peters T, Schroen B. 2014. Missing links in cardiology: Long non-coding RNAs enter the arena. Pflugers Arch 466: 1177–1187.
82. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, et al. 2010. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28: 848–855.
83. Porrello ER. 2013. microRNAs in cardiac development and regeneration. Clin Sci 125: 151–166.
84. Prall O WJ, Menon MK, Solloway MJ, Watanabe Y, Zaffran S, Bajolle F, Biben C, McBride JJ, Robertson BR, Chaulet H, et al. 2007. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 128: 947–959.
85. Qian L, Wythe JD, Liu J, Cartry J, Vogler G, Mohapatra B, Otway RT, Huang Y, King IN,Maillet M, et al. 2011. Tinman/Nkx2-5 acts via miR-1 and upstream of Cdc42 to regulate heart function across species. J Cell Biol 193: 1181–1196.
86. Ram O, Goren A, Amit I, Shoresh N, Yosef N, Ernst J, Kellis M, Gymrek M, Issner R, Coyne M, et al. 2011. Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells. Cell 147: 1628–1639.
87. Reecy JM, Li X, Yamada M, DeMayo FJ, Newman CS, Harvey RP, Schwartz RJ. 1999. Identification of upstream regulatory regions in the heart-expressed homeobox gene Nkx2-5. Development 126: 839–849.
88. Rojas A, Kong SW, Agarwal P, Gilliss B, Pu WT, Black BL. 2008. GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol Cell Biol 28: 5420–5431.
89. Rosa-Garrido M, Karbassi E,Monte E, Vondriska TM. 2013. Regulation of chromatin structure in the cardiovascular system. Circ J 77: 1389–1398.
90. Sandmann T, Jensen LJ, Jakobsen JS, Karzynski MM, Eichenlaub MP, Bork P, Furlong EE. 2006. A temporal map of transcription factor activity: mef2 directly regulates target genes at all stages of muscle development. Dev Cell 10: 797–807.
91. Saxena A, Tabin CJ. 2010. miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation. Proc Natl Acad Sci 107: 87–91.
92. Sayed D, He M, Yang Z, Lin L, Abdellatif M. 2013. Transcriptional regulation patterns revealed by high resolution chromatin immunoprecipitation during cardiac hypertrophy. J Biol Chem 288: 2546–2558.
93. Schlesinger J, Schueler M, Grunert M, Fischer JJ, Zhang Q, Krueger T, Lange M, Tönjes M, Dunkel I, Sperling SR. 2011. The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet 7: 1001313.
94. Schoenebeck JJ, Keegan BR, Yelon D. 2007. Vessel and blood specification override cardiac potential in anterior mesoderm. Dev Cell 13: 254–267.
95. Schonrock N, Harvey RP,Mattick JS. 2012. Long noncodin RNAs in cardiac development and pathophysiology. Circ Res 111: 1349–1362.
96. Shen T, Aneas I, Sakabe N, Dirschinger RJ, Wang G, Smemo S, Westlund JM, Cheng H, Dalton N, Gu Y, et al. 2011. Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function. J Clin Invest 121: 4640–4654.
97. Simoes FC, Peterkin T, Patient R. 2011. Fgf differentially controls cross-antagonism between cardiac and haemangioblast regulators. Development 138: 3235–3245.
98. Singh R, Hoogaars WM, Barnett P, Grieskamp T, Rana MS, Buermans H, Farin HF, Petry M, Heallen T, Martin JF, et al. 2012. Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation. Cell Mol Life Sci 69: 1377–1389.
99. Smith E, Shilatifard A. 2014. Enhancer biology and enhanceropathies. Nat Struct Mol Biol 21: 210–219.
100. Sparrow DB, Chapman G, Smith AJ, Mattar MZ, Major JA, O’Reilly VC, Saga Y, Zackai EH, Dormans JP, Alman BA, et al. 2012. A mechanism for gene-environment interaction in the etiology of congenital scoliosis. Cell 149: 295–306.
101. Sperling SR. 2011. Systems biology approaches to heart development and congenital heart disease. Cardiovasc Res 91: 269–278.
102. Spitz F, Furlong EE. 2012. Transcription factors: From enhancer binding to developmental control. Nat Rev Genetics 13: 613–626.
103. Stein AB, Jones TA, Herron TJ, Patel SR, Day SM, Noujaim SF, Milstein ML, Klos M, Furspan PB, Jalife J, et al. 2011. patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest 121: 2641–2650.
104. Stennard FA, Costa MW, Lai D, Biben C, Furtado MB, Solloway MJ, McCulley DJ, Leimena C, Preis JI, Dunwoodie SL, et al. 2005. Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development 132: 2451–2462.
105. Stergachis AB, Neph S, Reynolds A, Humbert R, Miller B, Paige SL, Vernot B, Cheng JB, Thurman RE, Sandstrom R, et al. 2013. Developmental fate and cellular maturity encoded in human regulatory DNA landscapes. Cell 154: 888–903.
106. Struhl G. 1981. A homeotic mutation transforming leg to antenna in Drosophila. Nature 292: 635–638.
107. Taft RJ, Pheasant M, Mattick JS. 2007. The relationship between non-protein-coding DNA and eukaryotic complexity. BioEssays 29: 288–299.
108. Tajbakhsh S, Rocheteau P, Le Roux I. 2009. Asymmetric cell divisions and asymmetric cell fates. Annu Rev Cell Dev Biol 25: 671–699.
109. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676.
110. Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB. 1988. MyoD1: A nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242: 405–411.
111. Tibshirani R. 1996. Regression shrinkage and selection via the lasso. J R Stat Soc 58: 267–288.
112. Vandenberg LN, Levin M. 2013. A unified model for left-right asymmetry? Comparison and synthesis of molecular models of embryonic laterality. Dev Biol 379: 1–15.
113. van den Boogaard M, Smemo S, Burnicka-Turek O, Arnolds DE, van deWerken HJ, Klous P, McKean D, Muehlschlegel JD, Moosmann J, Toka O, et al. 2014. A common genetic variant within SCN10A modulates cardiac SCN5A expression. J Clin Invest 124: 1844–1852.
114. Van Handel B, Montel-Hagen A, Sasidharan R, Nakano H, Ferrari R, Boogerd CJ, Schredelseker J, Wang Y, Hunter S, Org T, et al. 2012. Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium. Cell 150: 590–605.
115. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN. 2009. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17: 662–673.
116. Vidal M, Cusick ME, Barabasi AL. 2011. Interactome networks and human disease. Cell 144: 986–998.
117. Vierstra J, Wang H, John S, Sandstrom R, Stamatoyannopoulos JA. 2014. Coupling transcription factor occupancy to nucleosome architecture with DNase-FLASH. Nat Methods 11: 66–72.
118. Vincent SD, Buckingham ME. 2010. How to make a heart: The origin and regulation of cardiac progenitor cells. Curr Top Dev Biol 90: 1–41.
119. Waddington CH. 1957. The strategy of the genes: A discussion of some aspects of theoretical biology. Allen & Unwin, Crows Nest, New South Wales.
120. Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, Ding H, Wylie JN, Pico AR, Capra JA, et al. 2012. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 151: 206–220.
121. Watanabe Y, Zaffran S, Kuroiwa A, Higuchi H, Ogura T, Harvey RP, Kelly RG, Buckingham M. 2012. Fibroblast growth factor 10 gene regulation in the second heart field by Tbx1, Nkx2–5, and Islet1 reveals a genetic switch fordown-regulation in the myocardium. Proc Natl Acad Sci 109: 18273–18280.
122. Watt AJ, Battle MA, Li J, Duncan SA. 2004. GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci 101: 12573–12578.
123. Wilczynski B, Liu YH, Yeo ZX, Furlong EE. 2012. Predicting spatial and temporal gene expression using an integrative model of transcription factor occupancy and chromatin state. PLoS Comput Biol 8: 1002798.
124. Wystub K, Besser J, Bachmann A, Boettger T, Braun T. 2013. miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development. PLoS Genet 9: 1003793.
125. Xu X, Yin Z, Hudson JB, Ferguson EL, Frasch M. 1998. Smad proteins act in combination with synergistic and antagonistic regulators to target Dpp responses to the Drosophila mesoderm. Genes Dev 12: 2354–2370.
126. Yamagishi H, Yamagishi C, Nakagawa O, Harvey RP, Olson EN, Srivastava D. 2001. The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation. Dev Biol 239: 190–203.
127. Yamanaka S, Blau HM. 2010. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465: 704–712.
128. Yin Z, Xu XL, Frasch M. 1997. Regulation of the twist target gene tinman by modular cis-regulatory elements during early mesoderm development. Development 124: 4971–4982.
129. Zaret KS, Carroll JS. 2011. Pioneer transcription factors: Establishing competence for gene expression. Genes Dev 25: 2227–2241.
130. Zeineddine D, Papadimou E, Chebli K, Gineste M, Liu J, Grey C, Thurig S, Behfar A, Wallace VA, Skerjanc IS, et al. 2006. Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev Cell 11: 535–546.
131. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D. 2007. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129: 303–317.